Nitric oxide modulation of the hypothalmo-neurohypophyseal system

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 4, 2004, Pages 441-450

  Kadekaro, M ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

CGMP; L NAME; Microdialysis; ODQ; Oxytocin; Vasopressin

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC AMP; ANGIOTENSIN; ARGINASE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CYCLIC GMP; FREE RADICAL; GUANYLATE CYCLASE INHIBITOR; INDOMETACIN; MUSCARINIC RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NEUROHYPOPHYSIS HORMONE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYTOCIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; VASOPRESSIN;

BLEEDING; BLOOD VOLUME; BRAIN HOMOGENATE; BRAIN SLICE; DEHYDRATION; DOWN REGULATION; ENZYME INHIBITION; FLUID BALANCE; FOREBRAIN; GABAERGIC SYSTEM; HORMONE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOVOLEMIA; LACTATION; MAGNOCELLULAR NUCLEUS; MICRODIALYSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROHYPOPHYSIS DISEASE; NEUROMODULATION; NITROSYLATION; NONHUMAN; OSMOSIS; OXYTOCIN RELEASE; PATHOGENESIS; PROSTAGLANDIN SYNTHESIS; PROTEIN TARGETING; RAT; REVIEW; SIGNAL TRANSDUCTION; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; THIRD TRIMESTER PREGNANCY; UPREGULATION; VASOPRESSIN RELEASE;

EID: 2442516343     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000400001     Document Type: Review

References (60)

1. Garthwaite J & Boulton CL (1995). Nitric oxide signaling in the central nervous system. Annual Review of Physiology, 57: 683-706.
2. Nelson RJ, Kriegsfeld LJ, Dawson VL & Dawson TM (1997). Effects of nitric oxide on neuroendocrine function and behavior. Frontiers in Neuroendocrinology, 18: 463-491.
3. Kadekaro M & Summy-Long JY (2000). Centrally produced nitric oxide and the regulation of body fluid and blood pressure homeostases. Clinical and Experimental Pharmacology and Physiology, 27: 450-459.
4. Bradt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM & Snyder SH (1991). Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron, 7: 615-624.
5. Wang H & Morris JF (1996). Constitutive nitric oxide synthase in hypothalami of normal and hereditary diabetes insipidus rats and mice: role of nitric oxide in osmotic regulation and its mechanism. Endocrinology, 137: 1745-1751.
6. Yamada K, Emson P & Hokfelt T (1996). Immunohistochemical mapping of nitric oxide synthase in the rat hypothalamus and colocalization with neuropeptides. Journal of Chemical Neuroanatomy, 10: 295-316.
7. Luckman SM, Huckett L, Bicknell RJ, Voisin DL & Herbison AE (1997). Up-regulation of nitric oxide synthase messenger RNA in an integrated forebrain circuit involved in oxytocin secretion. Neuroscience, 77: 37-48.
8. Pasqualotto BA, Hope BT & Vincent SR (1991). Citrulline in the rat brain: immunohistochemistry and coexistence with NADPH-diaphorase. Neuroscience Letters, 128: 155-160.
9. Pow DV (1992). NADPH-diaphorase activity (nitric oxide synthase) staining in the rat supraoptic nucleus is activity-dependent: possible functional implications. Journal of Neuroendocrinology, 4: 377-380.
10. Terrell ML, Salas N, Bui V, Summy-Long JY & Kadekaro M (2004). NO inhibition of the magnocellular neuroendocrine system in rats is independent of cGMP signaling pathway. Experimental Neurology, 184: 846-856.
11. Kadowaki K, Kishimoto J, Leng G & Emson PC (1994). Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothalamo-hypophyseal system after chronic salt loading: Evidence of neuromodulatory role of nitric oxide in arginine vasopressin and oxytocin secretion. Endocrinology, 134: 1011-1017.
12. Ueta Y, Levy A, Chowdrey HS & Lightman SL (1995). Water deprivation in the rat induces nitric oxide synthase (NOS) gene expression in the hypothalamic paraventricular and supraoptic nuclei. Neuroscience Research, 23: 317-319.
13. Villar MJ, Ceccatelli S, Rönnquist M & Hökfelt T (1994). Nitric oxide synthase increases in hypothalamic magnocellular neurons after salt loading in the rat. An immunohistochemical and in situ hybridization study. Brain Research, 644: 273-281.
14. Ueta Y, Levy A, Lightman SL, Hara Y, Seino R, Nomura M, Shibuya I, Hattori Y & Yamashita H (1998). Hypovolemia upregulates the expression of nitric oxide synthase gene in the paraventricular and supraoptic nuclei of rats. Brain Research, 790: 25-32.
15. Sagar SM & Ferriero DM (1987). NADPH diaphorase activity in the posterior pituitary: relation to neuronal function. Brain Research, 400: 348-352.
16. Hatton GI (1997). Function-related plasticity in hypothalamus. American Review of Neuroscience, 20: 375-397.
17. Beagley GH & Cobbett P (1997). Inhibition of nitric oxide synthase induces ultrastructural changes in the neurohypophysis of dehydrated rats. Neuroscience Letters, 222: 143-146.
18. Liu QS, Jia YS & Ju G (1997). Nitric oxide inhibits neuronal activity in the supraoptic nucleus of the rat hypothalamic slices. Brain Research Bulletin, 43: 121-125.
19. Brenman JE, Chao DS, Gee SH et al. (1996). Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and a-1 syntrophin mediated by PDZ domains. Cell, 84: 757-767.
20. Meeker RB, Swanson DJ, Greenwood RS & Hayward JN (1993). Quantitative mapping of glutamate presynaptic terminals in the supraoptic nucleus and surrounding hypothalamus. Brain Research, 600: 112-122.
21. Brann DW (1995). Glutamate: a major excitatory transmitter in neuroendocrine regulation. Neuroendocrinology, 61: 213-225.
22. Theodosis DT, Paul L & Tappaz ML (1986). Immunocytochemical analysis of the GABAergic innervation of oxytocin- and vasopressin-secreting neurons in the rat supraoptic nucleus. Neuroscience, 19: 207-222.
23. Schrader LA & Tasker JG (1997). Presynaptic modulation by metabotrophic glutamate receptors of excitatory and inhibitory synaptic inputs to hypothalamic magnocellular neurons. Journal of Neurophysiology, 77: 527-536.
24. Bains JS & Ferguson AV (1997). Nitric oxide regulates NMDA-driven GABAergic inputs to type I neurons of the rat paraventricular nucleus. Journal of Physiology, 499: 733-746.
25. Cui LN, Inenaga K, Nagatoma T & Yamashita H (1994). Sodium nitroprusside modulates NMDA response in the rat supraoptic neurons in vitro. Brain Research Bulletin, 35: 253-260.
26. Ozaki M, Shibuya I, Kabashima N, Isse T, Noguchi J, Ueta Y, Inoue Y, Shigematsu A & Yamashita H (2000). Preferential potentiation by nitric oxide of spontaneous inhibitory postsynaptic currents in rat supraoptic neurons. Journal of Neuroendocrinology, 12: 273-281.
27. Stern JE & Ludwig M (2001). NO inhibits supraoptic oxytocin and vasopressin neurons via activation of GABAergic synaptic inputs. American Journal of Physiology, 280: R1815-R1822.
28. Srisawat R, Ludwig M, Bull PM, Douglas JJ, Russell JA & Leng G (2000). Nitric oxide and the oxytocin system in pregnancy. Journal of Neuroscience, 20: 6721-6727.
29. Okere CO, Wang Y-F, Higuchi T, Negoro H, Okutani F, Takahashi S & Murata T (1996). The effect of systemic and central nitric oxide administration on milk availability in lactating rats. NeuroReport, 8: 243-247.
30. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circulatory Research, 72: 387-395.
31. Chiu T & Reid IA (1995). Effect of inhibition of nitric oxide synthesis on the cardiovascular and endocrine responses to hemorrhage in conscious rabbits. Hypertension Research, 18: 55-61.
32. Goyer M, Bui H, Chou L, Evans J, Kiel LC & Reid IA (1994). Effect of inhibition of nitric oxide synthesis on vasopressin secretion in conscious rabbits. American Journal of Physiology, 266: H822-H828.
33. Chiodera P, Volpi R & Coiro V (1994). Inhibitory control of nitric oxide on the arginine-vasopressin and oxytocin response to hypoglycaemia in normal men. NeuroReport, 5: 1822-1824.
34. Cao L, Sun X & Shen E (1996). Nitric oxide stimulates both the basal and reflex release of vasopressin in anesthetized rats. Neuroscience Letters, 221: 49-52.
35. Yamaguchi K & Hama H (2003). A study on the mechanism by which sodium nitroprusside, a nitric oxide donor, applied to the anteroventral third ventricular region provokes facilitation of vasopressin secretion in conscious rats. Brain Research, 968: 35-43.
36. Ota M, Crofton JT, Festavan GT & Share L (1993). Evidence that nitric oxide can act centrally to stimulate vasopressin release. Neuroendocrinology, 57: 955-959.
37. Lutz-Bucher B & Koch B (1994). Evidence for an inhibitory effect of nitric oxides on neuropeptides secretion from isolated neural lobe of the pituitary gland. Neuroscience Letters, 165: 48-50.
38. Raber J & Bloom FE (1994). IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling. Journal of Neuroscience, 14: 6187-6195.
39. Yasin S, Costa A, Trainer P, Windle R, Forsling ML & Grossman A (1993). Nitric oxide modulates the release of vasopressin from rat hypothalamic explants. Endocrinology, 133: 1466-1469.
40. Verbalis JG, Mangione MP & Stricker EM (1991). Oxytocin produces natriuresis in rats at physiological plasma concentrations. Endocrinology, 128: 1317-1322.
41. Johnson AK, Cunningham JT & Thunhorst RL (1996). Integrative role of the lamina terminalis in the regulation of cardiovascular and body fluid homeostasis. Clinical and Experimental Pharmacology and Physiology, 23: 183-199.
42. Theodosis DT & Poulain DA (1984). Evidence for structural plasticity in the supraoptic nucleus of the rat hypothalamus in relation to gestation and lactation. Neuroscience, 11: 183-193.
43. Koehler EM, McLemore GL, Tang W & Summy-Long JY (1993). Osmoregulation of the magnocellular system during pregnancy and lactation. American Journal of Physiology, 264: R555-R560.
44. Okere CO & Higuchi T (1996) Down-regulation of endogenous nitric oxide synthase in late-pregnancy and parturition in the rat hypothalamic magnocellular neurons and neurohypophysis. Neuroscience Letters, 220: 133-136.
45. Summy-Long JY, Gestl S, Terrell ML, Wolz G & Kadekaro M (1997). Osmoregulation of the magnocellular neuroendocrine system during lactation. American Journal of Physiology, 272: R275-R288.
46. Southam E & Garthwaite J (1993). The nitric oxide-cyclic GMP signaling pathway in rat brain. Neuropharmacology, 32: 1267-1277.
47. 1 subunits of soluble guanylate cyclase in the rat brain. Molecular Brain Research, 20: 335-344.
48. Yang QZ & Hatton GI (1999). Nitric oxide via cGMP-dependent mechanisms increases dye coupling and excitability of rat supraoptic neurons. Journal of Neuroscience, 19: 4270-4279.
49. Briski KP (1999). Pharmacological manipulation of central nitric oxide/guanylate cyclase activity alters Fos expression by rat hypothalamic vasopressinergic neurons during acute glucose deprivation. Journal of Chemical Neuroanatomy, 17: 13-19.
50. Butler AR, Flitney FW & Williams DL (1995). NO, nitrosonium ions, nitroxide ions, nitrosothiols, and iron-nitrosyls in biology: a chemist's perspective. Trends in Pharmacological Sciences, 16: 18-22.
51. Pryor W, Church DF, Govindan C & Crank G (1982). Oxidation of thiols by nitric oxide and nitrogen dioxide: Synthetic utility and toxicological implications. Journal of Organic Chemistry, 47: 156-159.
52. Lander HM, Ogiste JS, Pearce SF, Levi R & Novogrodsky R (1995). Nitric oxide-stimulated guanine nucleotide exchange one p21 ras. Journal of Biological Chemistry, 270: 7017-7020.
53. Broillet MC & Firestein S (1996). Direct activation of the olfactory cyclic nucleotide-gated channel through modification of sulfhydryl groups by NO compounds. Neuron, 16: 377-385.
54. Molina y Vedia L, McDonald B, Reep B, Brune B, Di Silvio M, Billiar TR & Lapetina EG (1992). Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. Journal of Biological Chemistry, 267: 24929-24932.
55. Tenneti L, D'Emilia DM & Lipton SA (1997). Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neuroscience Letters, 236: 139-142.
56. Xu L, Eu JP, Meissner G & Stamler JS (1998). Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science, 279: 234-237.
57. Aizenman E, Lipton SA & Loring RH (1989). Selective modulation of NMDA responses by reduction and oxidation. Neuron, 2: 1257-1263.
58. Stamler JS, Lamas S & Fang FC (2001). Nitrosylation. The prototypic redox-based signaling mechanism. Cell, 106: 675-683.
59. Ahern GP, Hsu SF & Jackson MB (1999). Direct actions of nitric oxide on rat neurohypophyseal K+ channels. Journal of Physiology, 520: 165-176.
60. Kaczorowki GJ, Knaus HG, Leonard RJ, McManus OB & Garcia ML (1996). High-conductance calcium-activated potassium channels; structure, pharmacology, and function. Journal of Bioenergetics and Biomembranes, 28: 255-267.